Innovision Bio
範囲の調整、対象市場の協議、プロジェクト資料の管理経路を含む B2B 商務・プロジェクト調整。
Manufacturing & Quality
Featured on-site view: GuangLong manufacturing and R&D facility
B2B project coordination supported by entity-level quality documentation, reviewed for each relevant project.
プロジェクト上の役割
Innovision Bio は B2B の協議を調整します。文書、施設情報、許認可は各記録に記載された主体に帰属します。
範囲の調整、対象市場の協議、プロジェクト資料の管理経路を含む B2B 商務・プロジェクト調整。
製造・研究開発施設の背景情報。施設または製造に関する記述は、文書の名義人および記載範囲に限定されます。
独立して登記された商業主体です。医療機器の営業許可は、製品登録または製造許可ではありません。
Selected on-site views supporting B2B project review.
Representative operational view for project context; no certificate, test result or product release claim is implied.
Representative research-work view. Project-specific scope and documentation are reviewed separately.
Representative facility team activity for project context.
Representative operational view. Specific manufacturing conditions and release criteria are confirmed per project.
These reviewed documents are held by separately registered Chinese entities supporting Innovision Bio projects. Holder, stated scope, validity and project relevance are assessed individually.
Holder: Qufu Guanglong Bioproduct Factory. ISO 9001:2015 certificate shown valid from 12 Feb 2024 to 11 Feb 2027; its documented scope is reviewed for the relevant project.
Affiliated manufacturing entityHolder: Qufu Chuangxinli Biotechnology Co., Ltd. Class III medical-device business licence shown valid from 9 Jan 2025 to 8 Jan 2030. It is a business-operation licence, not a manufacturing authorisation or product registration.
Affiliated trading entityHolder: Qufu Guanglong Bioproduct Factory. Cosmetics production licence shown valid until 15 Nov 2026. Its documented scope does not approve an individual product or claim.
Affiliated manufacturing entityThese are entity-level documents, not product registrations, approvals or clinical evidence. Watermarked copies may be released only through the controlled-document process after holder authorisation and current-validity review.
Share your target market and project scope so the relevant entity, documentation pathway and next discussion can be reviewed.
お問い合わせ